US bans Pakistan’s PIA over pilot license scandal

So far 17 pilots have been fired in the first phase of Pakistan International Airlines’ investigation. (AFP)
Short Url
Updated 10 July 2020

US bans Pakistan’s PIA over pilot license scandal

  • Follows a similar move by European Union aviation regulators to bar the state-run carrier for six months

KARACHI: The United States has banned Pakistan International Airlines from operating chartered flights to the country, the airline said, after it announced nearly 150 pilots would be grounded over fake or dubious licenses.
It follows a similar move by European Union aviation regulators to bar the state-run carrier for six months.
PIA said in a statement that the Federal Aviation Authority in the US had revoked approval for the airline due to “recent events identified by the Pakistan Civil Aviation Authority that are of serious concern to aviation safety.”
Pakistan’s aviation minister revealed in June that a government review had found around 260 of the country’s 860 active pilots hold fake licenses or cheated on exams.
PIA at the time said it would immediately ground about a third of its 434 pilots, just weeks after one of its planes crashed in Karachi killing 98 people — an accident blamed on pilot error.
So far 17 pilots have been fired in the first phase of its investigation, a PIA spokesman said.
The airline had suspended its commercial operations to the US in 2017 after booking financial losses on the route.
But in April the US Department of Transport granted it special permission to operate chartered flights for one year, largely to bring back stranded Pakistanis during the coronavirus lockdown.
Until the 1970s, Pakistan’s largest airline was considered a top regional carrier but its reputation plummeted amid chronic mismanagement, frequent cancelations and financial struggles.


US to pay over $1 bn for 100 mln doses of J&J’s potential COVID-19 vaccine

Updated 05 August 2020

US to pay over $1 bn for 100 mln doses of J&J’s potential COVID-19 vaccine

  • The latest contract equates to roughly $10 per vaccine dose produced by J&J
  • This is J&J’s first deal to supply its investigational vaccine to a country

WASHINGTON: The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
J&J has already received $1 billion in funding from the US government — BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine.
The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the USgovernment, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc. and German biotech BioNTech SE.
The US government may also purchase an additional 200 million doses under a subsequent agreement. J&J did not disclose that deal’s value.
J&J plans to study a one- or two-dose regimen of the vaccine in parallel later this year. A single-shot regimen could allow more people to be vaccinated with the same number of doses and would sidestep issues around getting people to come back for their second dose.
This is J&J’s first deal to supply its investigational vaccine to a country. Talks are underway with the European Union, but no deal has yet been reached.
J&J’s investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early-stage study.
There are currently no approved vaccines for COVID-19. More than 20 are in clinical trials.